Plain-English translation of NCT06133426 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a smart scale — a device that measures your weight and connects to your doctor's computer — can help keep you safe while you're being treated for lymphoma or myeloma with chemotherapy. The idea is simple: by weighing yourself at home every day, your medical team can spot early warning signs of problems and step in quickly to help.
Blood cancer patients on chemotherapy can develop serious side effects quickly, and catching them early makes a big difference in treatment success. Right now, doctors usually only see patients at scheduled appointments. This study wants to see if checking weight at home between visits could help catch problems sooner.
You likely qualify if…
You likely don't qualify if…
You will use the connected scale once a day for about 7 weeks, preferably at the same time each day. Your weight and other health readings will be sent automatically to your doctor's team through a secure online platform. If the system detects any unusual changes, your medical team will be alerted and can contact you or adjust your care as needed. At the end of the study, you'll share your thoughts about how helpful the scale was.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
France